YGN 96.1 MDY 96.5 NPT 96.7

Back to News

Infotainment August 5, 2023

FDA approves first postpartum depression pill

The FDA has approved the first pill, called Zurzuvae, to treat severe postpartum depression in new mothers. Developed by Sage Therapeutics, the pill offers an oral treatment option that has shown strong effects in reducing depression symptoms over a four- to six-week period in studies. Zurzuvae works differently from traditional antidepressants, targeting a distinct brain pathway. While experts acknowledge its potential, some call for more extended follow-up data beyond the initial 45 days. The pill’s milder side effects and faster onset of benefits make it a notable alternative to existing treatments. Pricing details and its impact on prescription rates remain to be seen.

Source : CGTN

Our Podcast Avaliable On

You can listen to the programs organized by MI Radio on Google Podcast, Apple Podcast and Spotify.

Download Our App On

You can download MI Radio application on Google Play Store and Apple App Store.